Maria G. Tektonidou, Greece

Medical School, National and Kapodistrrian University of Athens First Department of Propaedeutic Internal Medicine
Maria Tektonidou is Professor of Rheumatology and Head of Rheumatology Unit of the First Department of Propaedeutic Internal Medicine at the University of Athens, School of Medicine, Greece. From 2009 to 2019 she has been working (1-2 monthly visits/year) as a Guest Researcher at the NIAMS/NIH. Dr. Tektonidou is a member of the Executive Committee of the ‘AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) (2014-present), and of the ‘European Lupus Society-SLEuro’ (2019-2020). She is a member of the ‘European Forum on Antiphospholipid Antibodies’ and the ‘EULAR study group on SLE’. She was a member of the ‘Task Force on Non-criteria APS Manifestations and on Catastrophic APS’ and the Task force group for ‘Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients’. She was co-author of the ‘EULAR recommendations for the management of SLE with neuropsychiatric manifestations’, the ‘Joint EULAR/ERA-EDTA recommendations for the management of adult and paediatric lupus nephritis’, the ‘EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with SLE and/or APS’ and the “2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus”. She has recently convened the ‘EULAR Recommendations for the management of APS in adults’ and she is currently a co-convenor of the “EULAR recommendations for the cardiovascular management of RMDs including SLE and APS”. She has participated as clinical investigator in several clinical trials on SLE and APS and she was invited speaker in several international meetings. Dr Tektonidou’s major research interests include the epidemiology, clinical manifestations and management, health-related quality of life, and long-term outcomes of patients with systemic autoimmune diseases, especially APS and SLE. She has over 180 peer-reviewed publications in international journals and book chapters with 10,780 citations and h-index 43 (Google Scholar). She is in the editorial board of two international journals and serves as a reviewer for 53 international journals.

Presenter of 2 Presentations

CARDIOVASCULAR RISK IN APS: SHOULD I CARE ABOUT?

Session Type
PARALLEL SESSIONS
Date
30.05.2021, Sunday
Session Time
15:30 - 17:30
Room
HALL A
Lecture Time
15:45 - 16:00
Session Icon
Pre Recorded

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND THE PATIENT

Session Type
PATIENT FORUM
Date
29.05.2021, Saturday
Session Time
09:00 - 13:10
Room
HALL G
Lecture Time
11:30 - 11:50
Session Icon
Pre Recorded